Dr. Patrick E. Williams has served on the National Scientific Review Board for the Human Genome Project, provided technical leadership to the Armed Forces DNA Technology Development Program and served on numerous NIH Study Sections on technology development.
Grouping strains by chemotyping may prove useful in ascertaining how strains are related, and the kind of medical benefits you can expect to see with strains from a given chemotype class.
WeedMD will contribute samples of 25 strains for cannabinoid composition analysis to create comprehensive profiles of each strains unique characteristics.
An early lab pilot of molecular tagging technology has demonstrated how members of the cannabis supply chain could be able to prove, with scientific certainty, that their products originate from their facilities or other legal sources.
Acreage plans to use supercritical CO2 extraction technology to produce safe, non-toxic, carbon-neutral, customizable, premium quality cannabis oils.
A Republican lawmaker has persuaded nearly the entire Legislature to sign on in support of his proposal to require medical marijuana to be tested for mold and agricultural chemicals.
Functional Remedies, Sunrise Genetics demonstrate the value of private partnerships to overcome challenges in the cannabis industry,
The rapid global adoption of legal cannabis legislation has accelerated the need to secure and truly validate cannabis supply chains from seed-to-sale.